ONTO Health, a prominent physician-led provider of fertility and longevity services, has announced its acquisition of LEVY Health. This strategic move, which follows a successful $20 million Series A funding round, integrates LEVY Health's clinical decision support software into ONTO's operations. The acquisition is a key step in ONTO Health's plan to build a scalable, technology-driven infrastructure for reproductive medicine.
Strategic Expansion and Market Growth
The integration of LEVY Health's platform is set to accelerate ONTO Health's expansion across the United States and into the Gulf Cooperation Council region. This growth strategy aims to address the increasing global demand for high-quality, personalized fertility treatments. The global fertility services market, valued at over $42 billion in 2023, is projected to exceed $70 billion by 2030, highlighting a significant opportunity.
Integrating Advanced Technology
Based in the US, LEVY Health has developed a sophisticated software platform that empowers healthcare providers to quickly identify endocrine disorders. Its technology streamlines the entire fertility workup process, enhancing efficiency and diagnostic precision for clinics. This focus on clinical decision support allows medical professionals to optimize their workflows and improve patient intake procedures significantly.
ONTO Health was founded by Dr. Roohi Jeelani, a double board-certified specialist in reproductive endocrinology and infertility. The company is committed to advancing its artificial intelligence capabilities to support clinical decision-making through automation and diagnostics. This technological focus is central to its mission of providing highly individualized treatment plans for patients seeking fertility and longevity care.
Leadership Perspectives on the Merger
Dr. Jeelani, CEO of ONTO Health, stated that the acquisition will be instrumental in scaling the company's mission. She emphasized that LEVY Health's superior diagnostics will provide practices with the necessary tools to integrate low-complexity fertility care into their existing models. This will foster a more distributed and collaborative ecosystem for reproductive health, benefiting both providers and patients.
Caroline Mitterdorfer, co-founder and CEO of LEVY Health, echoed this sentiment, highlighting the shared vision between the two companies. She explained that LEVY Health was created to make fertility care more efficient, precise, and accessible for providers. Joining ONTO Health extends this approach to a much broader network, enabling physicians to concentrate on delivering world-class clinical care.
A New Model for Reproductive Care
The acquisition reflects a unified belief in how fertility care should be delivered, emphasizing early access without compromising the patient experience. ONTO Health's philosophy combines personalized attention with evidence-based medicine to address factors impacting health throughout a person's lifespan. By treating fertility as a key indicator of overall health, the company partners with patients to manage long-term well-being proactively.
By integrating an advanced data infrastructure with proven integrative protocols, ONTO Health delivers earlier clinical insights and greater precision. This approach leads to highly individualized treatment plans that improve patient outcomes significantly. It also aims to reduce the time and burden often associated with the current standard of care in reproductive medicine.
Ultimately, the acquisition of LEVY Health by ONTO Health represents a significant step forward in the evolution of reproductive medicine. This strategic merger combines clinical expertise with advanced diagnostic technology to create a more scalable and efficient care model. The collaboration is poised to enhance patient access and outcomes, setting a new standard for personalized fertility and longevity care globally.